Capsaicin in digital osteoarthritis versus control : a randomized study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511159-16-00

Acronym

PHRC IR 2022 MATHIEU

Enrollment

120

Registered

2024-05-23

Start date

2025-02-14

Completion date

Unknown

Last updated

2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digital osteoarthritis

Brief summary

Finger pain intensity at eight weeks (W8) measured on a VAS ranging from 0 to 100 mm.

Interventions

DRUGcapsaïcine 0.04 %

DRUGQutenza 179 mg cutaneous patch

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Finger pain intensity at eight weeks (W8) measured on a VAS ranging from 0 to 100 mm.	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026